10 September 2015
Researchers have found an explanation that could lead to a deeper understanding of multiple sclerosis and more targeted treatment options for patients. By first looking broadly at possible environmental factors and then deeply at preclinical models of MS, the research team found that melatonin — a hormone involved in regulating a person’s sleep-wake cycle — may influence MS disease activity.
http://www.sciencedaily.com/releases/2015/09/150910131612.htm
